 |
 |
    |
|||
 The CompanyAdvisory BoardRecent NewsLinksContact Us
|
BioGenesis
Investment Group Investment Banking for the Biotech Industry For Public Biotech Firms: Corporate valuations derived from detailed technology valuations, showing the inherent strength of your company to the analyst and investment community. Development and implementation of stock value improvement plans. Technology acquisition and divestiture to bolster the development pipeline. For Private BioTech Firms: Defining the value of your technologies, developing a drug development funding plan and sourcing the needed capital. Sourcing and licensing complimentary technologies to increase the value of your company to the shareholders and capital markets. Defining technology/corporate acquisition or divestiture opportunities and coordinating these transitions through to successful completion. For Universities and Research Institutions: Marketing of your IP to outside buyers, thereby increasing revenue to the research institution. Defining the total value of your intellectual property portfolio. Introduction to, and partnering with, pharmaceutical firms looking for biotechnologies for their development pipelines. Meeting with researchers to examine the market value of their new discoveries prior to investing in patent coverage. Developing strategies for start-ups launched from the institution. For Public Market Stock Analysts: Detailed valuation reports of specific biotech companies showing the inherent strength or relative weakness of the company.
|
||||